Glutamate Receptors Are Focus of Schizophrenia Research
By: DOUG BRUNK, Clinical Psychiatry News Digital Network
LAS VEGAS ? In the opinion of Dr. Leslie Citrome, the clinical evidence for using adjunctive lithium and anticonvulsants in patients with schizophrenia is generally weak. Yet, clinicians continue to prescribe them.
"It?s kind of puzzling," Dr. Citrome said at the psychopharmacology conference sponsored by the Nevada Psychiatric Association...
[snip]
"Schizophrenia is many different diseases. It?s foolhardy to think that it?s all one pathophysiological process solved by one drug. Once we have a better idea of the different kinds of schizophrenia, then I think we?ll have greater chance and finding answers."
